Cardiovascular & Metabolic Disorders, Diseases News Articles

Cardiovascular and Metabolic Disorders

CARDIOVASCULAR AND METABOLIC DISORDERS

Featured Article

Latest News

Icosapent Ethyl sNDA Submitted for Expanded Indication to Reduce Major CV Events

By
Amarin has submitted a supplemental New Drug Application (sNDA) for Vascepa (icosapent ethyl) to reduce the risk of major cardiovascular (CV) events in the statin-treated population. Icosapent ethyl is a single-molecule consisting of the omega-3 acid commonly known as EPA in ethyl-ester form. It is currently indicated as an adjunct to diet to reduce triglyceride…
Next post in News